Company profileMixed portfolio#556 of 1,318 in Pakistan✓ No DRAP alerts

ORIENT LABORATORIES

Mixed portfolio · 11 pharmaceutical brands of 23 registrations

Ranked #31 of 32 companies in Antiinflammatory Agents And Antiinfectives In Combination

23 registered products 11 pharmaceutical brands 13 distinct molecules 0 DRAP alerts

Part of this company's portfolio (“Nutritional Supplement / Multivitamin”) is registered under a broad DRAP category rather than distinct molecules, so the molecule count understates its true range.

Company overview

registered products

pharmaceutical brands

distinct molecules

therapeutic classes

DRAP alerts

ORIENT LABORATORIES is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 23 product registrations across 13 distinct molecules. Its portfolio is concentrated in Antiinflammatory Agents And Antiinfectives In Combination. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Top molecules by brand count

Nutritional Supplement / Multivitamin13 brands

Chloramphenicol2 brands

Atropine1 brand

Oxytocin1 brand

Nikethamide1 brand

Pheniramine1 brand

Eye1 brand

Dexamethasone1 brand

Lignocaine1 brand

Adrenaline1 brand

Therapeutic classes

Regulatory record

✓

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

VENUS PHARMA7 shared molecules

DOSACO LABORATORIES6 shared molecules

ZAFA PHARMACEUTICAL LABORATORIES (PVT) LTD.6 shared molecules

AMROS PHARMACEUTICALS.6 shared molecules

REMINGTON PHARMACEUTICAL INDUSTRIES (PVT) LTD.6 shared molecules

OPHTH-PHARMA (PVT) LTD.6 shared molecules

SAFE PHARMACEUTICAL (PVT) LTD.5 shared molecules

Barrett Hodgson Pakistan (Private) Ltd.5 shared molecules

ZINTA PHARMACEUTICALS INDUSTRIES5 shared molecules

ETHICAL LABORATORIES PRIVATE LIMITED5 shared molecules

Get the full profile for ORIENT

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included